Oorsprong van het eerstegraads netwerk van Li Zhou
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
4
| Subsidiary | Miscellaneous Commercial Services | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Li Zhou via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
TRANSGENE | Biotechnology | Director/Board Member | |
INTEGRAGEN | Medical/Nursing Services | Director/Board Member | |
SCYNEXIS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Demeter Ventures SA
Demeter Ventures SA Investment ManagersFinance 123 Investment Managers SA is a Private Equity/Venture Capital firm, a subsidiary of Capucines Capital Partners SAS founded in 2000. 123 Investment Managers SA is headquartered in Grenoble. | Investment Managers | Director/Board Member | |
CELLECTIS S.A. | Pharmaceuticals: Major | Director/Board Member | |
Institut National de la Santé & de la Recherche Médicale
Institut National de la Santé & de la Recherche Médicale Miscellaneous Commercial ServicesCommercial Services Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
European Business School Group
European Business School Group Other Consumer ServicesConsumer Services The European Business School Group functions as a college or university. The company is based in Paris, France. | Other Consumer Services | Masters Business Admin | |
Ecole Polytechnique | College/University | Undergraduate Degree | |
Ecole Nationale de la Statistique & de l'Administration | College/University | Undergraduate Degree | |
University of Strasbourg | College/University | Undergraduate Degree | |
BPIFrance Investissement SAS
BPIFrance Investissement SAS Investment ManagersFinance BPIFrance Investissement SAS (BPIfrance Investissement) is the private equity arm and subsidiary of State-owned Banque Publique d'Investissement in France. Formerly known as CDC Entreprises SAS, the firm was established in 1994 to carry out public-interest missions such as employment creation and momentum initiation in the private equity field. In 2013 they became BPIfrance Investissement when CDC Entreprises, FSI and FSI Régions merged. Headquartered in Paris, BPIfrance Investissement invests of behalf of the Government of France, as well as for third parties including FEI-Fonds Européen d'Investissement, BEI-Banque Européenne d'Investissement and BPCE SA. The firm invests directly or indirectly in SMEs and intermediate-sized companies at all stages of their development. | Investment Managers | Private Equity Investor | |
French-American Chamber of Commerce
French-American Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The French-American Chamber of Commerce (FACC) is a non-profit, member-driven organization founded in 1985. The non-profit company is based in Atlanta, GA. The FACC is part of a network of 18 French-American chambers representing over 5,000 companies nationwide in all major industries. The company is also a proud member of CCI International, an international network of 124 French chambers of commerce in 95 countries, representing over 37,000 members worldwide. The FACC's mission is to promote, support, and enhance business opportunities among the French-American business community throughout the Southeast of the United States. The company provides opportunities for members to network, connect, collaborate, and learn from one another through events and programs. The FACC is the main professional forum and business resource for French companies and their leaders doing business in and with the Southeast of the United States, and for companies in the Southeast of the United States doing business in and with France. The company also provides a range of trade services to their local members and to French businesses and entrepreneurs seeking to develop their business in the Southeast of the United States. | Miscellaneous Commercial Services | President | |
University of Nice Sophia Antipolis | College/University | Doctorate Degree | |
CDC Croissance SA
CDC Croissance SA Investment ManagersFinance CDC Croissance SA is an asset management firm headquartered in Paris, France. It was founded in 2001 as CDC Entreprises Valeurs Moyennes SAS. The firm is a subsidiary of BPIFrance Investissement, which in turn is a subsidiary of government-owned Caisse d'Amortissement de la Dette Sociale. CDC Croissance manages assets of individual and institutional clients. | Investment Managers | Corporate Officer/Principal | |
ADOCIA | Pharmaceuticals: Major | Director/Board Member | |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance Kurma Partners SA (KP) is an independent venture capital firm founded in 2009 by Thierry Laugel. The firm is headquartered in Paris, France. | Investment Managers | Director/Board Member | |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Biotechnology | Director/Board Member | |
HepatoChem, Inc.
HepatoChem, Inc. Pharmaceuticals: MajorHealth Technology HepatoChem, Inc. provides pharmaceutical and biotech services. Its services include metabolite synthesis, chemical diversity, chemistry kits, metabolite structure elucidation, metabolic stability study and analytical services. The company was founded in 2008 by Marc Bazin and John T. Groves and is headquartered in Beverly, MA. | Pharmaceuticals: Major | Director of Finance/CFO | |
SAFE ORTHOPAEDICS SA | Medical Specialties | Director/Board Member | |
Aledia SAS
Aledia SAS Electrical ProductsProducer Manufacturing Aledia SAS develops and manufactures light-emitting diodes. Its products are based on 3D architecture using gallium-nitride-on-silicon microwires. The firm's technology uses silicon wafers and existing complementary metal-oxide semiconductor wafer-fabrication processes and tools, enabling production of LED chips. The company was founded by Giorgio Anania, Philippe Gilet, and Xavier Hugon in 2011 and is headquartered in Grenoble, France. | Electrical Products | Director/Board Member | |
ENYO Pharma SA
ENYO Pharma SA BiotechnologyHealth Technology ENYO Pharma SA operates as a biopharmaceutical company. The firm's research and development is focused on human infecting viruses, with the first two programs being dedicated to the treatment of severe and seasonal flu and chronic hepatitis B. The company was founded by Jacky Vonderscher, Jean-Jacques Garaud, Benoît de Chassey, Laurène Meyniel-Schicklin, Patrice André and Vincent Lotteau January 2014 and is headquartered in Lyon, France. | Biotechnology | Director/Board Member | |
SparingVision SAS
SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Emertee Gestion | Director/Board Member | ||
Yukin Therapeutics SAS
Yukin Therapeutics SAS Pharmaceuticals: MajorHealth Technology Yukin Therapeutics SAS manufactures pharmaceutical preparations. The company was founded by Matthieu Coutet on June 29, 2018 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer | |
Ribogenics, Inc.
Ribogenics, Inc. BiotechnologyHealth Technology Ribogenics, Inc. is a biotechnology company. The private company is based in Philadelphia, PA. The CEO of the company is Yves Joseph Ribeill. | Biotechnology | Director/Board Member | |
Alderaan Biotechnology SAS
Alderaan Biotechnology SAS BiotechnologyHealth Technology Alderaan Biotechnology SAS operates as preclinical stage firm, that develops monoclonal antibodies for the treatment of cancer. The company was founded by Daniel Olive and Armand Bensussan on July 17, 2017 and is headquartered in Paris, France. | Biotechnology | Chairman | |
Coretec Industry Group SAS
Coretec Industry Group SAS MiscellaneousMiscellaneous Coretec Industry Group SAS operates as a holding French company. The private company is based in Paris, France. | Miscellaneous | Director/Board Member | |
French Tech Hub
French Tech Hub Information Technology ServicesTechnology Services French Tech Hub provides technical expert services for companies. | Information Technology Services | Corporate Officer/Principal | |
Argobio SAS
Argobio SAS Miscellaneous Commercial ServicesCommercial Services Argobio SAS is a start-up studio founded in 2021 and based in Paris, FR. The company was initiated by Kurma Partners, a leading healthcare venture capital firm based in France, and Bpifrance, the French national investment bank. The French company aims to nurture and launch at least five breakthrough biotech companies over the next five years by sourcing innovative early-stage projects from renowned European academic research institutions. The focus is on selected therapeutic areas, including rare diseases, neurological disorders, oncology, and immunology. Argobio will identify, select, and incubate these projects up to company creation and beyond, providing broad expertise in the discovery and development of novel drugs with a team of highly experienced biotech entrepreneurs. The internal team is led by Yves Ribeill, Neill Mackenzie, Poul Sørensen, and Rémi Soula. Thierry Laugel, Managing Partner at Partners, is the President of Argobio. Kurma and Bpifrance were joined by complementary strategic investors, Angelini Pharma, a private international pharmaceutical company, Evotec, a drug discovery alliance and development partnership company, and the Institut Pasteur, an internationally renowned center for biomedical research. | Miscellaneous Commercial Services | Chairman | |
Axelia Partners LLC
Axelia Partners LLC Miscellaneous Commercial ServicesCommercial Services Part of Zedra Fund Managers (Guernsey) Ltd., Axelia Partners LLC provides administration, accounting, tax, paralegal and payroll services. The company is based in Cambridge, MA. The company was founded in 1989 by Marie-Yvonne Landel-Meunier. Axelia Partners was acquired by Zedra Fund Managers (Guernsey) Ltd. on November 14, 2022. | Miscellaneous Commercial Services | Founder | |
Women Initiative Foundation | Corporate Officer/Principal | ||
CELLNOVO | Medical Specialties | Director/Board Member | |
Pharmavent Partners | Chief Executive Officer |
Statistieken
Internationaal
Frankrijk | 31 |
Verenigde Staten | 8 |
Verenigd Koninkrijk | 2 |
Sectoraal
Health Technology | 15 |
Consumer Services | 7 |
Finance | 6 |
Commercial Services | 6 |
Health Services | 2 |
Operationeel
Director/Board Member | 23 |
Corporate Officer/Principal | 8 |
Independent Dir/Board Member | 6 |
Chairman | 3 |
Undergraduate Degree | 3 |